Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension | NEJM nejm.org Nawigacja wpisu Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate – Yahoo Finance Preparation over panic: How a Boston hospital is priming medical residents for an era of AI medicine – STAT
